[HTML][HTML] Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy

N Krawczyk, BD Rivera, E Levin… - The Lancet Public …, 2023 - thelancet.com
As the USA faces a worsening overdose crisis, improving access to evidence-based
treatment for opioid use disorder (OUD) remains a policy priority. Federal regulatory …

Opioid use disorder treatment for people experiencing homelessness: A scoping review

MF McLaughlin, R Li, ND Carrero, PA Bain… - Drug and alcohol …, 2021 - Elsevier
Background The opioid-related overdose epidemic remains a persistent public health
problem in the United States and has been accelerated by the 2019 coronavirus disease …

“It's like 'liquid handcuffs”: The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients' lives

D Frank, P Mateu-Gelabert, DC Perlman… - Harm Reduction …, 2021 - Springer
Abstract Background Methadone Maintenance Treatment (MMT) is widely recognized as
one of the most effective ways of reducing risk of overdose, arrest, and transmission of blood …

The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era

O Amram, S Amiri, V Panwala, R Lutz… - The American journal …, 2021 - Taylor & Francis
ABSTRACT Background Background: In response to the COVID-19 pandemic, the US
Substance Abuse and Mental Health Services Administration (SAMHSA) allowed for an …

The methadone manifesto: treatment experiences and policy recommendations from methadone patient activists

C Simon, L Vincent, A Coulter… - … Journal of Public …, 2022 - ajph.aphapublications.org
Abuse and Mental Health Services Administration (SAMHSA) released guidance to opioid
treatment programs relaxing some of the MMT restrictions that had been in place for more …

“You're not supposed to be on it forever”: Medications to treat opioid use disorder (MOUD) related stigma among drug treatment providers and people who use opioids

J Dickson-Gomez, A Spector, M Weeks… - Substance Abuse …, 2022 - journals.sagepub.com
Opioid use disorder (OUD) through prescription opioid misuse, heroin, and illicitly
manufactured fentanyl use has increased dramatically in the past 20 years. Medications to …

The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services

Y Aponte-Melendez, P Mateu-Gelabert, C Fong… - Harm reduction …, 2021 - Springer
Background While people who inject drugs (PWID) are vulnerable to the adverse outcomes
of events like COVID-19, little is known regarding the impact of the current pandemic on …

Telehealth for opioid use disorder treatment in low-barrier clinic settings: an exploration of clinician and staff perspectives

SV Aronowitz, E Engel-Rebitzer, A Dolan… - Harm reduction …, 2021 - Springer
Background The majority of individuals with opioid use disorder (OUD) face access barriers
to evidence-based treatment, and the COVID-19 pandemic has exacerbated the United …

[HTML][HTML] Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs

JM Kesten, A Holland, MJ Linton, H Family… - International Journal of …, 2021 - Elsevier
Background: People who inject drugs (PWID) are a high-risk group for COVID-19
transmission and serious health consequences. Restrictions imposed in the UK in response …

“The idea is to help people achieve greater success and liberty”: A qualitative study of expanded methadone take-home access in opioid use disorder treatment

LW Suen, S Castellanos, N Joshi… - Substance …, 2022 - journals.sagepub.com
Background: Prior to the COVID-19 pandemic, the United States (US) was already facing an
epidemic of opioid overdose deaths. Overdose deaths continued to surge during the …